Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

KALA

KALA BIO (KALA)

KALA BIO Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:KALA

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next >>

Date	Time	Source	Headline	Symbol	Company
03/23/2022	8:00AM	GlobeNewswire Inc.	Kala Pharmaceuticals to Report Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call	NASDAQ:KALA	KALA BIO Inc
03/22/2022	4:02PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KALA	KALA BIO Inc
03/09/2022	6:23AM	TipRanks	H.C. Wainwright Thinks Kala Pharmaceuticals’ Stock is Going to Recover	NASDAQ:KALA	KALA BIO Inc
03/08/2022	8:00AM	GlobeNewswire Inc.	Kala Pharmaceuticals Announces EYSUVIS® Now Covered on UnitedHealthcare Commercial and Cigna Medicare	NASDAQ:KALA	KALA BIO Inc
03/04/2022	5:02PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KALA	KALA BIO Inc
02/18/2022	4:00PM	GlobeNewswire Inc.	Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:KALA	KALA BIO Inc
12/17/2021	4:01PM	GlobeNewswire Inc.	Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:KALA	KALA BIO Inc
11/24/2021	2:28PM	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:KALA	KALA BIO Inc
11/18/2021	4:01PM	GlobeNewswire Inc.	Kala Pharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:KALA	KALA BIO Inc
11/15/2021	4:45PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:KALA	KALA BIO Inc
11/15/2021	8:59AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KALA	KALA BIO Inc
11/15/2021	8:47AM	GlobeNewswire Inc.	Kala Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update	NASDAQ:KALA	KALA BIO Inc
11/15/2021	8:45AM	GlobeNewswire Inc.	Kala Pharmaceuticals Acquires Combangio, Expanding its Pipeline with a Clinical-Stage Novel Biologic for the Treatment of Persistent Corneal Epithelial Defect (PCED) and other Rare Ocular Surface Diseases	NASDAQ:KALA	KALA BIO Inc
11/15/2021	7:00AM	GlobeNewswire Inc.	Kala Pharmaceuticals Announces Time Change for Third Quarter 2021 Financial Results Conference Call	NASDAQ:KALA	KALA BIO Inc
11/11/2021	8:00AM	GlobeNewswire Inc.	Kala Pharmaceuticals to Participate in Upcoming Investor Conferences in November 2021	NASDAQ:KALA	KALA BIO Inc
11/08/2021	4:01PM	GlobeNewswire Inc.	Kala Pharmaceuticals to Report Third Quarter 2021 Financial Results and Host Conference Call	NASDAQ:KALA	KALA BIO Inc
10/28/2021	4:24PM	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:KALA	KALA BIO Inc
10/22/2021	4:01PM	GlobeNewswire Inc.	Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:KALA	KALA BIO Inc
10/19/2021	4:09PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KALA	KALA BIO Inc
10/19/2021	4:08PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:KALA	KALA BIO Inc
10/18/2021	8:00AM	GlobeNewswire Inc.	Kala Pharmaceuticals Announces Appointment of C. Daniel Myers to Board of Directors	NASDAQ:KALA	KALA BIO Inc
10/14/2021	5:01PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:KALA	KALA BIO Inc
09/21/2021	4:01PM	GlobeNewswire Inc.	Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:KALA	KALA BIO Inc
09/07/2021	8:00AM	GlobeNewswire Inc.	Kala Pharmaceuticals to Present at Upcoming Investor Conferences in September 2021	NASDAQ:KALA	KALA BIO Inc
08/18/2021	4:01PM	GlobeNewswire Inc.	Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:KALA	KALA BIO Inc
08/05/2021	4:04PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:KALA	KALA BIO Inc
08/05/2021	7:02AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KALA	KALA BIO Inc
08/05/2021	7:00AM	GlobeNewswire Inc.	Kala Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update	NASDAQ:KALA	KALA BIO Inc
08/04/2021	8:00AM	GlobeNewswire Inc.	Kala Pharmaceuticals to Present at Upcoming Investor Conferences in August	NASDAQ:KALA	KALA BIO Inc
07/29/2021	8:00AM	GlobeNewswire Inc.	Kala Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call	NASDAQ:KALA	KALA BIO Inc

Showing the most relevant articles for your search:NASDAQ:KALA

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next >>

Seafarer Exploration (PK)

Good Vibrations Shoes (PK)

Fannie Mae (QB)

Trump Media and Technology

NioCorp Developments

Bell Buckle (PK)

Marketing Worldwide (PK)

Anavex Life Sciences

Global Developments (PK)

Kraig Biocraft Laborator... (QB)

Virexit Technologies (PK)

Delayed Upgrade Clock